About this episode

The episode discusses the potential and risks of psychedelic-assisted therapies in medicine.

Could psychedelics open new doors in medicine, or are patients being asked to trust the promise before the proof is in? Sign up for weekly webinars: Weekly Webinars - Independent Medical Alliance This episode of IMA’s Weekly Show aired Wednesday, April 29, 2026. Dr. Ryan Cole, IMA Head of Medical & Scientific Affairs, sits down with Dr. Molly Rutherford, IMA Senior Fellow in Family Medicine and Addiction Medicine, to separate hope from hype around psychedelic-assisted therapies. They discuss: • Why interest in psychedelic-assisted therapies is growing now • What the current science does and does not show • Why these substances have been difficult to study • The risks of moving too quickly toward unproven treatments • What responsible progress could look like for patients, families, and physicians The bottom line: when a treatment changes lives, it deserves to be studied carefully, not rushed blindly. First aired 29th April 2026 Also: • Donate: https://imahealth.org/donate/ • Follow: https://imahealth.org/contact/ • Webinar: https://imahealth.org/category/weekly-webinars/ • Treatment: https://imahealth.org/treatment-protocols/ • Medical Disclaimer…

People in this episode

Host: Dr. Ryan Cole

Guest: Dr. Molly Rutherford

Topics covered

• psychedelics
• medicine
• therapy
• addiction
• science
• patient care

Keywords

• psychedelics
• medicine
• therapy
• addiction
• research
• treatment

Mentioned in this episode

Organizations: IMA, Independent Medical Alliance

Explore listener stats, chart rankings, contacts and more on the IMA (Formerly FLCCC Alliance) podcast page.